Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Auton Neurosci. 2021 Mar 11;232:102796. doi: 10.1016/j.autneu.2021.102796

Table 2 -.

Cosinor Analysis

TG Controls (n = 6) ETB-def (n = 7)
Normal Salt High Salt Normal Salt High Salt 2-Way RM ANOVA (p)
SBP SD Amplitude (mmHg) 1.0 ± 0.1 1.7 ± 0.2 1.2 ± 0.2 2.2 ± 0.2S S = 0.0032 G = 0.0492 S*G = 0.4749
HR SD Amplitude (bpm) 7.5 ± 1.2 7.9 ± 0.5 8.8 ± 0.7 7.9 ± 1.5 S = 0.7123 G = 0.6319 S*G = 0.3825
SBP SD Acrophase (ZT) 20.5 ± 0.7 19.8 ± 0.2 20.3 ± 0.7 20.0 ± 0.5 S = 0.4140 G = 0.9608 S*G = 0.7426
HR SD Acrophase (ZT) 15.9 ± 0.9 15.9 ± 0.5 16.3 ± 0.2 16.3 ± 0.4 S = 0.9235 G = 0.4757 S*G = 0.9685

SBP: systolic blood pressure, HR: heart rate, Normal salt (0.49% NaCl), High salt (4.0% NaCl), G: genotype, S: salt diet. 2-way Repeated Measures ANOVA with Sidak’s post-hoc test for multiple comparisons:

S,

p < 0.05 vs. normal salt.Mean ± SEM.

Group effect significance indicated by italics.